Application of Implantable Polylactic-Co-Glycolic Acid Microcapsule in Repairing Alveolar Bone Defects.


Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2021
Historique:
received: 19 02 2021
revised: 01 06 2021
accepted: 16 07 2021
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 10 8 2021
Statut: epublish

Résumé

Alveolar bone defects (ABDs) were a perennial problem, especially in the aged. Bisphosphonates, especially etidronate sodium (ET), were frequently used in clinical treatment of ABD. However, the oral administration of ET had poor absorption (<1%). Therefore, optimization of a suitable dosage form substituted with ET to locally repair the ABD was a straightforward approach. Polylactide-co-glycolide (PLGA) is a biodegradable material and had been used in locally implanted medical devices. Therefore, an ET-PLGA microcapsule may help local delivery and prolong the activity of healing ABD. In this paper, a preparation method of ET-PLGA microcapsule was optimized by the single-factor investigation and response surface method. Subsequently, the rat ABD model was used to evaluate the enhancement effect of these microcapsules. Finally, the optimum parameters were determined as follows: 40% dichloromethane, 160 mg/mL PLGA, 10% internal aqua/oil phase, 4% PVA, and emulsifying for 10 min. These microcapsules were spherical in shape and fairly monodisperse in a particle size of 27,51 

Identifiants

pubmed: 34367304
doi: 10.1155/2021/5580785
pmc: PMC8337143
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5580785

Informations de copyright

Copyright © 2021 Jun Jiang et al.

Déclaration de conflit d'intérêts

All authors had no conflicts of interest regarding the publication of this study.

Références

ACS Appl Mater Interfaces. 2018 Nov 7;10(44):37855-37864
pubmed: 30299076
J Pharm Pharmacol. 2002 Jun;54(6):757-63
pubmed: 12078991
AAPS PharmSciTech. 2016 Aug;17(4):891-7
pubmed: 26416284
Colloids Surf B Biointerfaces. 2015 Oct 1;134:287-94
pubmed: 26209779
Pharmazie. 2008 Oct;63(10):721-5
pubmed: 18972833
Int Immunopharmacol. 2018 Sep;62:277-286
pubmed: 30036771
Polymers (Basel). 2011 Sep 1;3(3):1377-1397
pubmed: 22577513
J Biomed Mater Res A. 2017 Sep;105(9):2510-2521
pubmed: 28509410
Stem Cells Dev. 2019 Dec 15;28(24):1620-1631
pubmed: 31663419
Langmuir. 2011 Aug 16;27(16):10265-73
pubmed: 21766809
J Clin Periodontol. 2012 Jun;39(6):565-73
pubmed: 22486310
J Control Release. 1999 Feb 1;57(2):171-85
pubmed: 9971898
Adv Drug Deliv Rev. 2000 Aug 31;42(3):175-95
pubmed: 10963835
Colloids Surf B Biointerfaces. 2018 Mar 1;163:146-154
pubmed: 29291500
J Vis Exp. 2013 Dec 27;(82):51015
pubmed: 24429733
Acta Biomater. 2019 Feb;85:282-293
pubmed: 30605770
Pediatr Radiol. 2018 Mar;48(3):308-316
pubmed: 29143199
Sci Rep. 2020 Oct 1;10(1):16217
pubmed: 33004873
Sci Rep. 2019 Dec 3;9(1):18175
pubmed: 31796797
J Control Release. 2012 Jul 20;161(2):505-22
pubmed: 22353619
Braz Dent J. 2016 May-Jun;27(3):267-72
pubmed: 27224558
Med Phys. 2019 Jan;46(1):152-164
pubmed: 30414272
Comput Biol Med. 2017 Nov 1;90:15-22
pubmed: 28917119
Implant Dent. 2019 Oct;28(5):510-513
pubmed: 31135650
Int J Mol Sci. 2014 Feb 28;15(3):3640-59
pubmed: 24590126
Expert Opin Pharmacother. 2005 Mar;6(3):465-77
pubmed: 15794737
Osteoporos Int. 2008 Jun;19(6):733-59
pubmed: 18214569
Pharm Dev Technol. 2018 Oct;23(8):751-760
pubmed: 28378604
Biomed Res Int. 2018 Jul 5;2018:6762146
pubmed: 30069475
Nanotechnology. 2014 Feb 28;25(8):085702
pubmed: 24492410
Arch Intern Med. 2003 Oct 13;163(18):2237-46
pubmed: 14557222
Langmuir. 2013 Nov 19;29(46):14082-8
pubmed: 24164350
Colloids Surf B Biointerfaces. 2017 Oct 1;158:190-196
pubmed: 28692874
Int J Pharm. 2006 Oct 31;324(1):27-36
pubmed: 16949775
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):833-8
pubmed: 23706923
Pharm Res. 2017 Dec;34(12):2779-2786
pubmed: 28924739
Pharmazie. 2017 Sep 1;72(9):525-528
pubmed: 29441979
Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
pubmed: 10837562

Auteurs

Jun Jiang (J)

School of Pharmacy, Jiangsu University, 301# Xuefu Road, Zhenjiang 212013, Jiangsu Province, China.

Jianpeng Xiao (J)

School of Pharmacy, Jiangsu University, 301# Xuefu Road, Zhenjiang 212013, Jiangsu Province, China.

Dongqing Wang (D)

Affiliated Hospital of Jiangsu University, Department of Medical Imaging, Zhenjiang 212001, Jiangsu Province, China.

Huazhong Cai (H)

School of Pharmacy, Jiangsu University, 301# Xuefu Road, Zhenjiang 212013, Jiangsu Province, China.
Affiliated Hospital of Jiangsu University, Department of Medical Imaging, Zhenjiang 212001, Jiangsu Province, China.
Affiliated Hospital of Jiangsu University, Department of Emergency, Zhenjiang 212001, Jiangsu Province, China.

Classifications MeSH